EPIDEMIOLOGICAL CHARACTERISTICS OF PROSTATE CANCER IN THE MALE POPULATION OF THE ODESA REGION

Authors

DOI:

https://doi.org/10.32782/2226-2008-2023-4-8

Keywords:

epidemiological characteristics, prostate cancer

Abstract

Prostate cancer (PC) is the second most common type of cancer among men worldwide and is the fifth leading cause of cancer death in men. The purpose and task of the present work is to analyze the frequency and structure of the PC incidence in the male population of the Odesa region for the period from 2018 to 2020; to identify regional features of the frequency and structure of prostate cancer in the cities and districts of the region. The object of the study is statistical data on the primary detection of prostate cancer in 26 districts, 7 cities and the regional center – Odesa – for 3 years, from 2018 to 2020. The indicators of the National Cancer Register and Odesa Regional Clinical Oncology Dispensary for the period from 2018 to 2020 were analyzed for establishing the epidemiological characteristics of PC in the male population of the Odesa region. The analysis of the quantitative indicators of the PC incidence among the districts of the Odesa region indicates significant heterogeneity and variability of these values. Although the Odesa region is characterized by an average incidence rate of PC compared to national indicators, during the observation period this difference increased downwards, thus, in 2020 this indicator was 21.8 ± 2.15 per 100 thousand population. Geographical differences between the region’s districts, as well as differences in the socio-demographic status of the population and their combination, can determine the difference in the PC incidence rates between the districts of the Odesa region. Based on the analysis of the epidemiological status of PC among the districts of the Odesa region, the peculiarities of the dynamics of the PC incidence and their territorial dependence were identified and the following conclusions were formulated: 1. The PC incidence rate among residents of the Odesa region corresponds to the national indicators but had a downward trend for the period of 2018-2020. 2. The difference in the PC incidence rates between the districts of the Odesa region is related to their geographical differences and the socio-demographic status of the population.

References

Torre L.A., Siegel R.L., Ward E.M., Jema A. Global Cancer Incidence and Mortality Rates and Trends-An Update. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27.

Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence of incidence and mortality worldwide for 36 cancers in 185 countries. CA CANCER J CLIN. 2018; 68:394-424.

Detsyk O.Z., Rudko I.V. Analysis of morbidity and mortality from malignant neoplasms of the lip and oral cavity in Ukraine and Ivano-Frankivsk region for 2007-2016. Ukraine. The health of the nation. 2017;3(44):95-100. (In Ukrainian)

Zhou C.K., Сheck D.P., Lortet-Tieulent J., Laversanne M., Jemal A., Ferlay J., Bray F., Cook M.B., Devesa S.S. Prostate cancer incidence in 43 populations worldwide: AN analysis of time trends of time trends overall and by age group. Int J Cancer. 2016 Mar 15;138(6):1388-1400.

Stewart R.W., Lizama S., Peairs K., Sateia H.F., Choi Y.J. Screening for prostate cancer. Seminars in Oncology. 2017 Feb;44 (1):47-56.

Venkatesan A.M., Stafford R.J., Duran C., Soni P.D., Berlin A., McLaughlin P.W. Prostate magnetic resonance imaging for brachytherapists: Anatomy and technique. Brachytherapy. 2017 Jul – Aug;16(4):679-687.

Lee D.J., Mallin K., Graves A.J., Chang S.S., Penson D.F., Resnick M.J., Brocas D.A. Recent Changes in Prostate Cancer Screening Practices and Epidemiology. J Urol. 2017 Dec; 198(6):1230-1240.

Bashir M.N. Epidemiology of Prostate Cancer. Asian Pac J Cancer Prev. 2015;16(13):5137-41.

Blackwelder R., Chessman A. Prostate Cancer Screening: Shared Decision-Making for Screening and Treatment. Prim Care. 2019 Mar;46(1):149-155.

Perin N.N. Global variation in cancer incidence and mortality. Curr. Sci. 2001;81, 465-474.

Published

2023-12-28

Issue

Section

CLINICAL PRACTICE